( ?pid=3699>AT&T Wisconsin said his co...)TDS warns of continuing "Vishing" attempts
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
TDS warns of continuing "Vishing" attempts
?pid=3699">AT&T Wisconsin, said his company appreciates TDS' efforts to help consumers and businesses avoid being slammed or deceived by the unethical business practices of suspicious marketers. He said AT&T would join TDS in cautioning potential victims to be on the lookout for fraudulent marketing behavior.
TDS urges customers to check directly with the company by calling 1-888-CALL......
Full article >>>
'"/>
Source:wistechnology.com By WTN News 07/20/06
Related biology technology :
1. Investor warns of angel-venture funding gap
2. Journalist warns against late arrival to the tech party
3. Rodney Dykehouse of Froedtert and Medical College of Wisconsin warns against tech for its own sake
4. Minnesota, Missouri see continuing health care investments; Wisconsin lags
Post Your Comments:
Breaking Biology Technology:EUCODIS Bioscience Appoints Thomas Fischer as New CEO 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 2Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2
[0] EUCODIS Bioscience Appoints Thomas Fischer as New CEO[0] Merrimack Pharmaceuticals Acquires Hermes Biosciences, Inc. [0] RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE)[0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
Other Biology Technology:LifeNet Health Chief Scientific Officer Wins Award 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 3BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 4BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 5BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 6BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 7BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 8
Breaking Biology News(10 mins):Fish with attitude: Some like it hot 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Research is vital to a cleaner, greener, low carbon future 2Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 1Salient Mobility Launches the Text For a Cause 28TM 29 Campaign in Raising Awareness Through Wireless Health Tips 48763 2Over half of people with rheumatoid arthritis have periodontitis 48758 1Over half of people with rheumatoid arthritis have periodontitis 48758 2Over half of people with rheumatoid arthritis have periodontitis 48758 3National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 1National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 2National Quality Forum Welcomes Dr Thomas Valuck SVP of Strategic Partnerships 48754 3
Other Biology News:The brain's executive is an 'event planner' 2Finding paves way for better treatment of autoimmune disease 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 2Basic work on E. coli identifies two new keys to regulation of bacterial gene expression 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |